TABLE 5.
Treatment | Rating | Comments |
---|---|---|
Chemotherapy and ISRT | 9 | |
Chemotherapy and IFRT | 6 | |
Chemotherapy alone | 6 | |
Duration of ABVD (if chemotherapy given alone) | ||
2 cycles | 2 | |
4 cycles | 5 | |
6 cycles | 7 | This option assumes interim PET was negative after 4 cycles of chemotherapy |
Duration of ABVD (combined modality) | ||
2 cycles | 5 | This option may be appropriate but there was disagreement among panel members on the appropriateness rating as defined by the panel’s median rating |
4 cycles | 6 | |
6 cycles | 4 | |
Dose of radiation therapy (combined modality) | ||
20 Gy | 5 | This option may be appropriate but there was disagreement among panel members on the appropriateness rating as defined by the panel’s median rating |
30 Gy | 7 | |
30 Gy + 6 Gy boost to mediastinum | 5 |
Rating scale: 1, 2, 3 usually not appropriate; 4, 5, 6 may be appropriate; 7, 8, 9 usually appropriate.
ABVD indicates doxorubicin, bleomycin, vinblastine, and dacarbazine; ESR, erythrocyte sedimentation rate; IFRT, involved field radiation therapy; ISRT, involved site radiation therapy; PET/CT, positron emission tomography/computed tomography.